Clinical Research Directory
Browse clinical research sites, groups, and studies.
Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge
Sponsor: M.D. Anderson Cancer Center
Summary
This clinical trial studies contrast enhanced spectral mammography (CESM) for the evaluation of pathologic nipple discharge. CESM is similar to standard mammography, but it includes an intravenous (by vein) injection of an iodine-based contrast, which makes tissue and blood vessels more visible in scans. The goal of this trial is to learn if CESM, is better than standard mammography in quickly and efficiently determining the cause of nipple discharge and detecting breast cancer, if present. CESM may increase the chance of finding breast cancers and lower the risk of having unnecessary biopsies.
Official title: Contrast Enhanced Spectral Mammography (CESM) for the Evaluation of Pathologic Nipple Discharge: A Pilot Study
Key Details
Gender
FEMALE
Age Range
25 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
66
Start Date
2021-04-15
Completion Date
2027-04-30
Last Updated
2025-10-09
Healthy Volunteers
No
Conditions
Interventions
Contrast Enhanced Digital Mammography
Undergo CESM
Digital Tomosynthesis Mammography
Undergo DBT
Iodinated Contrast Agent
Given iodine-based contrast agent IV
Questionnaire Administration
Ancillary studies
Locations (1)
M D Anderson Cancer Center
Houston, Texas, United States